Long‐term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction‐associated fatty liver disease in adults with obesity and type 2 diabetes-Reference-Cited by-同舟云学术

Long‐term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction‐associated fatty liver disease in adults with obesity and type 2 diabetes

Published:2024-09-12 Issue: Volume: Page:
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Lundholm Michelle D.¹^ORCID,Kirschling Sarah²,Hu Bo²,Aminian Ali³^ORCID,Arterburn David E.⁴^ORCID,Courcoulas Anita P.⁵,Cummings David E.⁶,Gourash William F.⁵,Patti Mary Elizabeth⁷^ORCID,Schauer Philip R.⁸,Simonson Donald C.⁹^ORCID,Vernon Ashley H.¹⁰,Kirwan John P.¹¹,Kashyap Sangeeta R.¹²^ORCID

Affiliation:

1. Department of Endocrinology Diabetes and Metabolism Cleveland Clinic Cleveland Ohio USA

2. Department of Quantitative Health Sciences Cleveland Clinic Cleveland Ohio USA

3. Bariatric and Metabolic Institute, Department of General Surgery Cleveland Clinic Cleveland Ohio USA

4. Kaiser Permanente Washington Health Research Institute Seattle Washington USA

5. Department of Surgery University of Pittsburgh Pittsburgh Pennsylvania USA

6. Department of Metabolism, Endocrinology, and Nutrition University of Washington and VA Puget Sound Health Care System Seattle Washington USA

7. Research Division Joslin Diabetes Center, and Harvard Medical School Boston Massachusetts USA

8. Metamor Institute Pennington Biomedical Research Center Baton Rouge Louisiana USA

9. Division of Endocrinology, Diabetes and Hypertension Brigham and Women's Hospital, and Harvard Medical School Boston Massachusetts USA

10. Division of General & GI Surgery Brigham and Women's Hospital, and Harvard Medical School Boston Massachusetts USA

11. Pennington Biomedical Research Center Baton Rouge Louisiana USA

12. Weill Cornell Medicine Department of Medicine, Division of Endocrinology Diabetes and Metabolism New York New York USA

Funder

Inatai Foundation

National Institute of Diabetes and Digestive and Kidney Diseases

Ethicon

Covidien

Publisher

Wiley

Reference26 articles.

1. Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity

2. The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods

3. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

4. Can Nonalcoholic Steatohepatitis Be Surgically Cured?